Notice: This company has been marked as potentially delisted and may not be actively trading. ARYA Sciences Acquisition Corp IV (ARYD) News Today Add Compare Share Share Headlines Stock AnalysisHeadlinesOwnershipShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Arya Sciences Acquisition Corp Share Price (ARYD.US)August 5, 2024 | lse.co.ukAdagio Medical Holdings Inc. - Ordinary Shares - Class AAugust 2, 2024 | money.usnews.comARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Trading Up 0.3%ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Shares Up 0.3%July 16, 2024 | marketbeat.comHsbc Holdings PLC Buys Shares of 149,910 ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD)Hsbc Holdings PLC purchased a new position in shares of ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 149,910 shares of the company's stock, valued at apJune 8, 2024 | marketbeat.comShort Interest in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Decreases By 50.0%ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD - Get Free Report) saw a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 100 shares, a decline of 50.0% from the April 30th total of 200 shares. Based on an average daily volume of 14,400 shares, the short-interest ratio is presently 0.0 days.May 29, 2024 | marketbeat.comMizuho Securities USA LLC Grows Stock Position in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD)Mizuho Securities USA LLC grew its position in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD - Free Report) by 218.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 332,532 shares oMay 19, 2024 | marketbeat.comShort Interest in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Declines By 60.0%ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD - Get Free Report) was the recipient of a significant decrease in short interest in April. As of April 30th, there was short interest totalling 200 shares, a decrease of 60.0% from the April 15th total of 500 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average trading volume of 36,900 shares, the days-to-cover ratio is presently 0.0 days.May 11, 2024 | marketbeat.comARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Short Interest UpdateARYA Sciences Acquisition Corp IV (NASDAQ:ARYD - Get Free Report) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 500 shares, a growth of 400.0% from the March 31st total of 100 shares. Based on an average trading volume of 40,500 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are sold short.April 25, 2024 | marketbeat.comShort Interest in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Drops By 87.5%ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD - Get Free Report) saw a large decline in short interest in the month of March. As of March 31st, there was short interest totalling 100 shares, a decline of 87.5% from the March 15th total of 800 shares. Based on an average daily volume of 39,800 shares, the short-interest ratio is presently 0.0 days.April 10, 2024 | marketbeat.comARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Sees Significant Increase in Short InterestARYA Sciences Acquisition Corp IV (NASDAQ:ARYD - Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 800 shares, an increase of 14.3% from the February 29th total of 700 shares. Based on an average daily trading volume, of 37,500 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the shares of the stock are short sold.March 31, 2024 | marketbeat.comARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Sees Large Decline in Short InterestARYA Sciences Acquisition Corp IV (NASDAQ:ARYD - Get Free Report) saw a significant drop in short interest in February. As of February 29th, there was short interest totalling 700 shares, a drop of 99.5% from the February 14th total of 128,500 shares. Based on an average trading volume of 36,400 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the company's stock are short sold.March 12, 2024 | marketbeat.comAdagio Medical to go public in $113M deal with SPAC ARYA SciencesFebruary 14, 2024 | msn.comAdagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation TechnologiesFebruary 14, 2024 | finance.yahoo.comAdagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation TechnologiesFebruary 14, 2024 | prnewswire.comWestchester Capital Management LLC Trims Holdings in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD)Westchester Capital Management LLC cut its holdings in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD - Free Report) by 17.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 419,078 shares of the company's stock afterFebruary 6, 2024 | marketbeat.com8-K: ARYA Sciences Acquisition Corp IVApril 7, 2023 | marketwatch.comWestchester Capital Management LLC Acquires New Shares in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD)Westchester Capital Management LLC bought a new position in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD - Get Rating) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 337,577 shares of the company's stock, valued at appMarch 15, 2023 | marketbeat.comFir Tree Capital Management LP Buys Shares of 33,784 ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD)Fir Tree Capital Management LP acquired a new position in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD - Get Rating) during the 3rd quarter, according to its most recent filing with the SEC. The fund acquired 33,784 shares of the company's stock, valued at approximately $335,000. Fir Tree CapitalMarch 3, 2023 | marketbeat.comARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus' Gene Therapy Business Due to Market ConditionsFebruary 24, 2022 | benzinga.comMoore Kuehn Encourages KOR, DISCA, FTSI, and ARYD Investors to Contact Law FirmNovember 30, 2021 | finance.yahoo.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of EJF, HTPA, ARYD, and ADER MergersNovember 9, 2021 | finance.yahoo.comMoore Kuehn Encourages NOTV, ARYD, XLRN, and TGP Investors to Contact Law FirmOctober 6, 2021 | finance.yahoo.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of ARYA Sciences Acquisition Corp. IV MergerOctober 1, 2021 | finance.yahoo.comAmcius (FOLD) to Spin-Off Gene Therapy Arm, Form New Firm With ARYASeptember 30, 2021 | entrepreneur.comAmicus Therapeutics Stock Rises; Sells Unit Stake in SPAC DealSeptember 30, 2021 | msn.comAmicus stock is up 5%, the day after announcing plans to sell its gene therapy businessSeptember 30, 2021 | finance.yahoo.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of ARYA Sciences Acquisition Corp IV (Nasdaq - ARYD)September 29, 2021 | finance.yahoo.comPerceptive Advisors-Backed SPAC To Acquire Amicus's Gene Therapy BusinessSeptember 29, 2021 | feeds.benzinga.comAmicus Therapeutics and ARYA Sciences Acquisition Corp IV Announce Formation of a ...September 29, 2021 | apnews.comAmicus Therapeutics and ARYA Sciences Acquisition Corp IV Announce Formation of a Next-Generation Genetic Medicine Company: “Caritas Therapeutics”September 29, 2021 | finance.yahoo.com Get ARYA Sciences Acquisition Corp IV News Delivered to You Automatically Sign up to receive the latest news and ratings for ARYD and its competitors with MarketBeat's FREE daily newsletter. Email Address 2025: Digital Asset Insights You Need to Know (Ad)Cryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto. Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential. Get your guide today! ARYD Media Mentions By Week ARYD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARYD News Sentiment▼0.000.49▲Average Medical News Sentiment ARYD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARYD Articles This Week▼00▲ARYD Articles Average Week Get ARYA Sciences Acquisition Corp IV News Delivered to You Automatically Sign up to receive the latest news and ratings for ARYD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Tristar Acquisition I News City Office REIT News Ellington Credit News Investcorp India Acquisition News SilverBox Corp III News Forge Global News EVe Mobility Acquisition News SK Growth Opportunities News Spark I Acquisition News Granite Point Mortgage Trust News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARYD) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARYA Sciences Acquisition Corp IV Please log in to your account or sign up in order to add this asset to your watchlist. Share ARYA Sciences Acquisition Corp IV With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
